Riskpilot← Back to searchSign inGet full accessDiagentec AB
ABActiveOrg 5569528663Upplands VäsbyWholesale of pharmaceutical and medical goods · NACE 4646Est. 20134 employees
Revenue 2024
SEK 4M
0% vs 2023
EBITDA margin
-103.9%
-25% vs 2023
Equity ratio
2.3%
Financial strength
Net profit 2024
SEK 654K
+10807% vs 2023
| Revenue | SEK 4M | +0% |
| EBITDA | SEK -4,2M | -25% |
| Net profit | SEK 654K | +10807% |
| Total assets | SEK 54,4M | -13% |
| Equity | SEK 1,2M | +112% |
| Employees | 4 | — |
Legal name
Diagentec AB
Org number
5569528663
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10 december 2013
Share capital
SEK 100 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Finnström, David Niklas Lindberg, VidarDessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva handelsverksamhet avseende utrustning för genteknologi och proteinkemi, samt därmed förenlig verksamhet.
Address
Upplands Väsby
Email
post@diagen.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 224 115 | 138 075 | 84 113 | 3 999 | 4 018 |
| Staff expenses | — | — | — | — | −5 096 |
| EBITDA | 99 668 | 59 807 | 32 632 | −3 351 | −4 174 |
| Depreciation & amort. | −1 164 | −1 056 | −839 | −280 | −241 |
| EBIT | 98 504 | 58 751 | 31 793 | −3 631 | −4 415 |
| Net financials | −118 | −242 | −14 | 1 453 | 1 257 |
| Profit before tax | 74 699 | 45 752 | 25 685 | 409 | 1 330 |
| Tax | −16 018 | −9 504 | −5 459 | −403 | −676 |
| Net profit | 58 681 | 36 248 | 20 226 | 6 | 654 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 131 019 | 140 314 | 91 971 | 62 342 | 54 419 |
| Equity | 67 103 | 36 351 | 20 577 | 583 | 1 238 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 23 628 | 50 918 | 12 256 | 5 208 | 1 118 |
| Total debt | 23 628 | 50 918 | 12 256 | 5 208 | 1 118 |
EBITDA margin
-103.9%
This company
15.8%
Market median
-758% vs market
20202024
Equity ratio
2.3%
This company
38.2%
Market median
-94% vs market
20202024
Return on equity
52.9%
This company
18.4%
Market median
+188% vs market
20202024
Net profit margin
16.3%
This company
8.1%
Market median
+101% vs market
20202024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20202024
Debt / equity
42.96×
This company
0.62×
Market median
-6829% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
NE Chief Executive Officer | Chief Executive Officer | 2021 |
MJ Chief Auditor | Chief Auditor | 2021 |
VL Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DIAGEN AS
Diagentec AB (this company)Board members of Diagentec AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Egil Håkan Evefors | Chief Executive Officer | 0 companies |
| Mats Johan Jakobsson | Chief Auditor | 0 companies |
| Vidar Lindberg | Deputy Chief Executive Officer | 0 companies |
| Vegard Kjaerheim | Board of Directors | 0 companies |
| David Niklas Finnström | Board of Directors | 0 companies |
| Peter Csango | Board of Directors | 0 companies |